Skip to content

Utah Medical Products UTMD Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

TFX
TeleflexTFX
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
IAR
Integra LifeSciencesIART
UFP Technologies logo
UFP TechnologiesUFPT
InfuSystem Holdings logo
InfuSystem HoldingsINFU
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's allowance for doubtful accounts?
Utah Medical Products (UTMD) reported allowance for doubtful accounts of $515K in Q4 2025.
How has Utah Medical Products's allowance for doubtful accounts changed year-over-year?
Utah Medical Products's allowance for doubtful accounts increased by 260.1% year-over-year, from $143K to $515K.
What is the long-term trend for Utah Medical Products's allowance for doubtful accounts?
Over 5 years (2020 to 2025), Utah Medical Products's allowance for doubtful accounts has grown at a 30.9% compound annual growth rate (CAGR), from $134K to $515K.